These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

944 related items for PubMed ID: 30659266

  • 1. The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network.
    Cheng M, Sheng L, Gao Q, Xiong Q, Zhang H, Wu M, Liang Y, Zhu F, Zhang Y, Zhang X, Yuan Q, Li Y.
    Oncogene; 2019 May; 38(19):3667-3680. PubMed ID: 30659266
    [Abstract] [Full Text] [Related]

  • 2. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q, Wei JF, Yang H.
    Mol Cancer; 2019 Jun 22; 18(1):110. PubMed ID: 31228940
    [Abstract] [Full Text] [Related]

  • 3. METTL3/YTHDF2 m6 A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.
    Xie H, Li J, Ying Y, Yan H, Jin K, Ma X, He L, Xu X, Liu B, Wang X, Zheng X, Xie L.
    J Cell Mol Med; 2020 Apr 22; 24(7):4092-4104. PubMed ID: 32126149
    [Abstract] [Full Text] [Related]

  • 4. METTL3 Regulates the Translation of Oncogene Myc through m6A Modification and Promotes the Occurrence and Development of Cervical Cancer.
    Ma Y, Shi H, Zheng W.
    Discov Med; 2024 Sep 22; 36(188):1902-1910. PubMed ID: 39327253
    [Abstract] [Full Text] [Related]

  • 5. METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS.
    Chen JX, Chen DM, Wang D, Xiao Y, Zhu S, Xu XL.
    Oncol Rep; 2023 May 22; 49(5):. PubMed ID: 36960869
    [Abstract] [Full Text] [Related]

  • 6. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.
    Liu C, Ren Q, Deng J, Wang S, Ren L.
    Biomed J; 2024 Aug 22; 47(4):100664. PubMed ID: 37774794
    [Abstract] [Full Text] [Related]

  • 7. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, Wong CC, Ng IO, Wong CM.
    Hepatology; 2018 Jun 22; 67(6):2254-2270. PubMed ID: 29171881
    [Abstract] [Full Text] [Related]

  • 8. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J, Xie H, Ying Y, Chen H, Yan H, He L, Xu M, Xu X, Liang Z, Liu B, Wang X, Zheng X, Xie L.
    Mol Cancer; 2020 Oct 29; 19(1):152. PubMed ID: 33121495
    [Abstract] [Full Text] [Related]

  • 9. The m6A Methylation-Regulated AFF4 Promotes Self-Renewal of Bladder Cancer Stem Cells.
    Gao Q, Zheng J, Ni Z, Sun P, Yang C, Cheng M, Wu M, Zhang X, Yuan L, Zhang Y, Li Y.
    Stem Cells Int; 2020 Oct 29; 2020():8849218. PubMed ID: 32676121
    [Abstract] [Full Text] [Related]

  • 10. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B, Song C, Yang L, Cui R, Cheng X, Zhang Z, Zhao G.
    Mol Cancer; 2019 Oct 13; 18(1):142. PubMed ID: 31607270
    [Abstract] [Full Text] [Related]

  • 11. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma.
    Chai RC, Chang YZ, Chang X, Pang B, An SY, Zhang KN, Chang YH, Jiang T, Wang YZ.
    J Hematol Oncol; 2021 Jul 10; 14(1):109. PubMed ID: 34246306
    [Abstract] [Full Text] [Related]

  • 12. Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma.
    Guo S, Chen F, Li L, Dou S, Li Q, Huang Y, Li Z, Liu W, Zhang G.
    J Adv Res; 2024 Jul 10; 61():165-178. PubMed ID: 37619934
    [Abstract] [Full Text] [Related]

  • 13. METTL3/METTL14 Transactivation and m6A-Dependent TGF-β1 Translation in Activated Kupffer Cells.
    Feng Y, Dong H, Sun B, Hu Y, Yang Y, Jia Y, Jia L, Zhong X, Zhao R.
    Cell Mol Gastroenterol Hepatol; 2021 Jul 10; 12(3):839-856. PubMed ID: 33992834
    [Abstract] [Full Text] [Related]

  • 14. HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification.
    Yang Z, Jiang X, Li D, Jiang X.
    Aging (Albany NY); 2020 Oct 13; 12(24):24967-24982. PubMed ID: 33048840
    [Abstract] [Full Text] [Related]

  • 15. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Ni Z, Sun P, Zheng J, Wu M, Yang C, Cheng M, Yin M, Cui C, Wang G, Yuan L, Gao Q, Li Y.
    Cancer Res; 2022 May 03; 82(9):1789-1802. PubMed ID: 35502544
    [Abstract] [Full Text] [Related]

  • 16. METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8-mediated neutrophil infiltration.
    He J, Zhou M, Yin J, Wan J, Chu J, Jia J, Sheng J, Wang C, Yin H, He F.
    Mol Ther; 2021 May 05; 29(5):1821-1837. PubMed ID: 33484966
    [Abstract] [Full Text] [Related]

  • 17. METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.
    Li T, Hu PS, Zuo Z, Lin JF, Li X, Wu QN, Chen ZH, Zeng ZL, Wang F, Zheng J, Chen D, Li B, Kang TB, Xie D, Lin D, Ju HQ, Xu RH.
    Mol Cancer; 2019 Jun 24; 18(1):112. PubMed ID: 31230592
    [Abstract] [Full Text] [Related]

  • 18. N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer.
    Jin H, Ying X, Que B, Wang X, Chao Y, Zhang H, Yuan Z, Qi D, Lin S, Min W, Yang M, Ji W.
    EBioMedicine; 2019 Sep 24; 47():195-207. PubMed ID: 31409574
    [Abstract] [Full Text] [Related]

  • 19. METTL3-dependent N6-methyladenosine RNA modification mediates the atherogenic inflammatory cascades in vascular endothelium.
    Chien CS, Li JY, Chien Y, Wang ML, Yarmishyn AA, Tsai PH, Juan CC, Nguyen P, Cheng HM, Huo TI, Chiou SH, Chien S.
    Proc Natl Acad Sci U S A; 2021 Feb 16; 118(7):. PubMed ID: 33579825
    [Abstract] [Full Text] [Related]

  • 20. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y, Liu S, Luo H, Wu S, Wei H, Tang Z, Li X, Lv X, Zou C.
    J Immunol Res; 2021 Feb 16; 2021():6149558. PubMed ID: 34476262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.